Silk Road Medical Stock Annual Yield
SILKDelisted Stock | USD 27.49 0.00 0.00% |
Silk Road Medical fundamentals help investors to digest information that contributes to Silk Road's financial success or failures. It also enables traders to predict the movement of Silk Stock. The fundamental analysis module provides a way to measure Silk Road's intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to Silk Road stock.
Silk |
Silk Road Medical Company Annual Yield Analysis
Silk Road's Yield generally refers to the amount of cash that is paid back to the owner of a security over a specific time (usually one year). It is expressed as a percentage of current market price, and usually amounts to all the interests and/or dividends paid over a given period. A higher yield allows the shareholders to generate returns on their investments sooner. However, investors should also be aware that a high yield may be a result of market turmoil or increased price volatility.
Small firms, start-ups, or companies with high growth potential typically do not pay out dividends or distribute a lot of their profits. These companies will have small yield. Alternatively, more established companies, ETFs, and funds that invest in bonds will have higher yields.
CompetitionIn accordance with the recently published financial statements, Silk Road Medical has an Annual Yield of 0.0%. This indicator is about the same for the Health Care Equipment & Supplies average (which is currently at 0.0) sector and about the same as Health Care (which currently averages 0.0) industry. This indicator is about the same for all United States stocks average (which is currently at 0.0).
Did you try this?
Run Positions Ratings Now
Positions RatingsDetermine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance |
All Next | Launch Module |
Silk Fundamentals
Return On Equity | -0.36 | |||
Return On Asset | -0.14 | |||
Profit Margin | (0.30) % | |||
Operating Margin | (0.34) % | |||
Current Valuation | 1.02 B | |||
Shares Outstanding | 40.63 M | |||
Shares Owned By Insiders | 4.15 % | |||
Shares Owned By Institutions | 97.46 % | |||
Number Of Shares Shorted | 3.15 M | |||
Price To Book | 7.22 X | |||
Price To Sales | 5.83 X | |||
Revenue | 177.13 M | |||
Gross Profit | 100.76 M | |||
EBITDA | (55.48 M) | |||
Net Income | (55.74 M) | |||
Cash And Equivalents | 108.87 M | |||
Cash Per Share | 3.09 X | |||
Total Debt | 84.63 M | |||
Debt To Equity | 1.37 % | |||
Current Ratio | 6.92 X | |||
Book Value Per Share | 3.81 X | |||
Cash Flow From Operations | (32.01 M) | |||
Short Ratio | 2.48 X | |||
Earnings Per Share | (1.45) X | |||
Price To Earnings To Growth | (0.26) X | |||
Target Price | 20.75 | |||
Number Of Employees | 474 | |||
Beta | 1.54 | |||
Market Capitalization | 1.12 B | |||
Total Asset | 265.31 M | |||
Retained Earnings | (399.45 M) | |||
Working Capital | 210.55 M | |||
Net Asset | 265.31 M |
About Silk Road Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Silk Road Medical's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Silk Road using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Silk Road Medical based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Building efficient market-beating portfolios requires time, education, and a lot of computing power!
The Portfolio Architect is an AI-driven system that provides multiple benefits to our users by leveraging cutting-edge machine learning algorithms, statistical analysis, and predictive modeling to automate the process of asset selection and portfolio construction, saving time and reducing human error for individual and institutional investors.
Try AI Portfolio ArchitectCheck out World Market Map to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in bureau of economic analysis. You can also try the Idea Breakdown module to analyze constituents of all Macroaxis ideas. Macroaxis investment ideas are predefined, sector-focused investing themes.
Other Consideration for investing in Silk Stock
If you are still planning to invest in Silk Road Medical check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Silk Road's history and understand the potential risks before investing.
Share Portfolio Track or share privately all of your investments from the convenience of any device | |
Portfolio Suggestion Get suggestions outside of your existing asset allocation including your own model portfolios | |
Idea Analyzer Analyze all characteristics, volatility and risk-adjusted return of Macroaxis ideas | |
Fundamental Analysis View fundamental data based on most recent published financial statements | |
Funds Screener Find actively-traded funds from around the world traded on over 30 global exchanges | |
Transaction History View history of all your transactions and understand their impact on performance |